Cargando…

Development of small-molecule transforming growth factor beta antagonists

Detalles Bibliográficos
Autores principales:	Warner, DJ, Sessions, RB, Dawbarn, D, Prime, SS, Allen, SJ, Paterson, IC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300284/ http://dx.doi.org/10.1186/bcr1592

Ejemplares similares

Inhibition of Tax transformation activity using a small molecule targeting Tax/PDZ domain interactions
por: Blibek, Karim, et al.
Publicado: (2014)

IL-1 beta receptor antagonist efficacy in the treatment of idiopathic recurrent pericarditis
por: Picco, P, et al.
Publicado: (2008)

Is transforming growth factor beta signalling required for breast cancer metastatic cell motility?
por: Giampieri, S, et al.
Publicado: (2006)

Epigenetic silencing of tropomyosin alters transforming growth factor beta control of cell invasion and metastasis
por: Bakin, A, et al.
Publicado: (2005)

Association of gene variants in the transforming growth factor beta signalling pathways with invasive breast cancer risk
por: Scollen, S, et al.
Publicado: (2006)

Transforming growth factor beta 1 gene transcription in infection and severe sepsis displays distinguishing characteristics
por: White, M, et al.
Publicado: (2008)

Inhalation injury and clinical course in major burned patients
por: Henrich, S, et al.
Publicado: (2014)

Effects of transforming growth factor beta-1 on growth-regulatory genes in tumour-derived human oral keratinocytes.
por: Paterson, I. C., et al.
Publicado: (1995)

Dynamic information system for small molecules
por: Telukunta, Kiran K, et al.
Publicado: (2014)

Laminin type 1 augments the transforming growth factor beta-induced expression of matrix metalloproteinase 3 in synovial fibroblasts
por: Hoberg, M, et al.
Publicado: (2005)

The effects of the climatic elements on occurrence of the spontaneous pneumothorax
por: Haam, SJ, et al.
Publicado: (2013)

5613391 SUBCLINICAL NEPHROTOXICITY IN PATIENTS WITH BETA-THALASSEMIA: ROLE OF URINARY KIDNEY INJURY MOLECULE
por: Zakaria, M., et al.
Publicado: (2023)

Colorectal cancer patients show decrease in cellular immunity and enhanced plasma level of transforming growth factor – beta and vascular endothelial growth factor (VEGF)
por: Zavadova, Eva, et al.
Publicado: (2013)

Attachment of synovial fibroblasts to type 1 laminin boosts the transforming growth factor beta-induced expression of stromelysin-1 (MMP-3)
por: Aicher, WK
Publicado: (2004)

The potential of small molecules to modulate glycosylation by media design
por: Brühlmann, David, et al.
Publicado: (2015)

Transforming growth factor-beta co-receptor endoglin suppresses breast cancer invasion and metastasis
por: Henry, LA, et al.
Publicado: (2010)

Evaluation of a weaning protocol in an intensive care unit
por: Pivoto, RB, et al.
Publicado: (2007)

Different molecules at the surface of stimulated T cells induce IL-1α, tumor necrosis factor and IL-1 receptor antagonist in human monocytes
por: Burger, D, et al.
Publicado: (2004)

Activation of synovial fibroblasts by laminin-1 and transforming growth factor beta induces expression of stromelysins independently of TNFα, IL-1β or NF-κB
por: Warstat, Katrin, et al.
Publicado: (2007)

MycPermCheck: the Mycobacterium tuberculosis permeability prediction tool for small molecules
por: Merget, Benjamin, et al.
Publicado: (2013)

A data mining approach for identifying novel target specific small molecules
por: Khanna, Varun, et al.
Publicado: (2014)

Different molecules at the surface of stimulated T cells induce IL-1beta, tumour necrosis factor and IL-1RA in human monocytes
por: Burger, D, et al.
Publicado: (2005)

Novel role of platelet endothelial cell adhesion molecule-1 (PECAM-1) in facilitating TGF-beta-mediated inhibition of T cell function
por: Newman, Debra, et al.
Publicado: (2015)

Selective inhibition of Toll-like receptor 4 signaling by the small molecule TAK-242
por: Kawamoto, T, et al.
Publicado: (2006)

Host-guest mediated sensing of biologically relevant small molecules using supramolecular nanoassembly
por: Pandya, Alok, et al.
Publicado: (2014)

Interleukin-1 antagonists in Mevalonate Kinase Deficiency
por: Galeotti, C, et al.
Publicado: (2011)

Ceramides and glucosylceramides are independent antagonists of insulin action
por: Chavez, Jose A, et al.
Publicado: (2012)

Towards automated metabolome assembly: application of text mining to correlate small molecules, targets and tissues
por: Moreno, P, et al.
Publicado: (2011)

A novel small-molecule SIRT1 inhibitor induces apoptosis in leukemic cell lines
por: Kozako, Tomohiro, et al.
Publicado: (2014)

Immunomodulation and infection: identification of small molecule TLR3 blockers to combat deleterious inflammation in pneumonia
por: Sônego, F, et al.
Publicado: (2014)

TRU-015, a small modular immunopharmaceutical (SMIP™) drug candidate directed against CD20, demonstrates clinical improvement in subjects with rheumatoid arthritis
por: Burge, DJ, et al.
Publicado: (2007)

PriaXplore(® )- a novel technology platform for the identification of small molecule modulators of protein-protein interactions
por: Eyrisch, Susanne, et al.
Publicado: (2013)

TNF-alpha antagonists for treatment of juvenile ankylosing spondylitis
por: Orbán, I, et al.
Publicado: (2011)

Epstein-Barr virus induces adhesion molecule CD226 (DNAM-1) expression during primary B cell transformation into lymphoblastoid cell lines
por: Grossman, Lisa V, et al.
Publicado: (2012)

Beta lactam hypersensitivities
por: Azoury, Marie Eliane*, et al.
Publicado: (2014)

Novel function of GATA-3, revealed by conditional deficient mice
por: Ho, IC, et al.
Publicado: (2003)

VX-166, a novel potent small molecule caspase inhibitor, as a promising new treatment for sepsis
por: Weber, P, et al.
Publicado: (2006)

Preclinical assessment of a novel small molecule inhibitor of indoleamine 2,3-dioxygenase 1 (IDO1)
por: Driessens, Gregory, et al.
Publicado: (2014)

Preclinical assessment of a novel small molecule inhibitor of tryptophan 2,3-dioxygenase 2 (TDO2)
por: Crosignani, Stefano, et al.
Publicado: (2014)

Discovery of a natural antagonist of macrophage migration inhibitory factor
por: Al-Abed, Y, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_0vosdbmne58lm15o1qru9v616n